| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
50,394 |
46,648 |
$5.92M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
28,904 |
26,890 |
$3.92M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
11,435 |
8,684 |
$3.54M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
11,699 |
10,426 |
$1.65M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
17,255 |
5,250 |
$1.35M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
10,646 |
7,671 |
$890K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
7,187 |
6,792 |
$777K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
7,001 |
3,127 |
$608K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,353 |
1,955 |
$551K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,281 |
1,961 |
$542K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,198 |
1,871 |
$536K |
| G0378 |
Hospital observation service, per hour |
5,674 |
3,096 |
$416K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
1,110 |
1,028 |
$408K |
| 11043 |
|
1,402 |
595 |
$328K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,177 |
1,022 |
$320K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,580 |
1,254 |
$314K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,449 |
720 |
$261K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
25,069 |
20,433 |
$238K |
| 11045 |
|
998 |
414 |
$227K |
| 80053 |
Comprehensive metabolic panel |
30,459 |
25,715 |
$223K |
| 93356 |
|
798 |
688 |
$213K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
5,003 |
4,660 |
$190K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
675 |
580 |
$175K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
387 |
351 |
$165K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,360 |
1,224 |
$160K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
999 |
959 |
$156K |
| 59025 |
Fetal non-stress test |
969 |
658 |
$153K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,257 |
1,018 |
$138K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
8,255 |
7,474 |
$133K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,106 |
572 |
$130K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
314 |
280 |
$124K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
6,253 |
5,262 |
$88K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,778 |
1,660 |
$84K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
362 |
338 |
$79K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
448 |
378 |
$73K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
56,611 |
47,196 |
$72K |
| 84484 |
|
17,196 |
10,112 |
$67K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
589 |
524 |
$60K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,038 |
897 |
$57K |
| 80061 |
Lipid panel |
3,916 |
3,654 |
$55K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
168 |
158 |
$53K |
| 43248 |
|
174 |
163 |
$43K |
| 71046 |
Radiologic examination, chest; 2 views |
2,957 |
2,730 |
$43K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,763 |
1,626 |
$43K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,554 |
3,081 |
$43K |
| 80076 |
|
7,889 |
7,214 |
$42K |
| 36415 |
Collection of venous blood by venipuncture |
26,562 |
19,267 |
$41K |
| 12001 |
|
255 |
230 |
$41K |
| 97162 |
|
1,083 |
951 |
$40K |
| 95886 |
|
141 |
116 |
$38K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
20,315 |
17,479 |
$35K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
284 |
226 |
$35K |
| 76642 |
|
215 |
211 |
$31K |
| 73221 |
|
158 |
146 |
$30K |
| 93017 |
|
383 |
345 |
$30K |
| 71045 |
Radiologic examination, chest; single view |
11,974 |
10,668 |
$30K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,673 |
676 |
$30K |
| 82805 |
|
1,052 |
850 |
$29K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
173 |
149 |
$29K |
| 71250 |
|
282 |
253 |
$27K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
2,217 |
2,093 |
$26K |
| 76830 |
Ultrasound, transvaginal |
355 |
320 |
$26K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,319 |
2,120 |
$25K |
| 97161 |
|
547 |
479 |
$25K |
| 82607 |
|
1,556 |
1,394 |
$24K |
| 10060 |
|
140 |
123 |
$23K |
| 29580 |
|
237 |
111 |
$20K |
| 97607 |
|
198 |
82 |
$18K |
| J1756 |
Injection, iron sucrose, 1 mg |
826 |
298 |
$16K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
637 |
266 |
$16K |
| 86850 |
|
839 |
682 |
$16K |
| 93971 |
|
205 |
186 |
$16K |
| 95811 |
|
27 |
27 |
$16K |
| 94060 |
|
116 |
101 |
$16K |
| 80069 |
|
1,185 |
825 |
$16K |
| 85027 |
|
4,478 |
2,994 |
$15K |
| 97166 |
|
386 |
323 |
$15K |
| J3490 |
Unclassified drugs |
4,035 |
2,502 |
$15K |
| 72100 |
|
598 |
544 |
$15K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
117 |
104 |
$14K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
886 |
737 |
$14K |
| 96367 |
|
761 |
471 |
$14K |
| 84100 |
|
1,924 |
1,549 |
$13K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
26 |
24 |
$13K |
| 29581 |
|
137 |
64 |
$13K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
9,612 |
6,727 |
$13K |
| 83735 |
|
5,656 |
3,548 |
$13K |
| 86900 |
|
1,079 |
877 |
$12K |
| 97165 |
|
254 |
212 |
$12K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
45 |
41 |
$12K |
| 73030 |
|
832 |
674 |
$11K |
| 84439 |
|
765 |
665 |
$11K |
| 90715 |
|
661 |
567 |
$10K |
| 82746 |
|
1,405 |
1,261 |
$10K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
16,220 |
14,097 |
$10K |
| 93970 |
|
84 |
75 |
$9K |
| 70496 |
|
44 |
41 |
$9K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
8,170 |
7,312 |
$9K |
| 81001 |
|
18,948 |
17,114 |
$9K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
41 |
41 |
$8K |
| 86803 |
|
382 |
347 |
$8K |
| 73130 |
|
751 |
646 |
$8K |
| 82728 |
|
1,651 |
1,444 |
$8K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
676 |
568 |
$8K |
| 76770 |
|
69 |
59 |
$8K |
| 94726 |
|
109 |
97 |
$8K |
| 94729 |
|
111 |
99 |
$8K |
| 73562 |
|
697 |
596 |
$8K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
36 |
27 |
$7K |
| 76801 |
|
38 |
27 |
$7K |
| 93270 |
|
73 |
66 |
$7K |
| 72040 |
|
162 |
151 |
$7K |
| 73630 |
|
845 |
746 |
$6K |
| 36591 |
|
1,672 |
785 |
$6K |
| 83540 |
|
1,505 |
1,297 |
$6K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
29 |
25 |
$6K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
10,462 |
8,008 |
$6K |
| 72131 |
|
116 |
95 |
$5K |
| 80320 |
|
454 |
380 |
$5K |
| 84436 |
|
592 |
544 |
$5K |
| 93880 |
|
72 |
67 |
$5K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
583 |
565 |
$5K |
| 97597 |
|
296 |
153 |
$5K |
| 86140 |
|
657 |
472 |
$5K |
| 83550 |
|
1,476 |
1,273 |
$5K |
| 96376 |
|
1,906 |
1,062 |
$5K |
| 73502 |
|
373 |
315 |
$5K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
27 |
25 |
$4K |
| 85610 |
|
2,566 |
2,019 |
$4K |
| 73610 |
|
744 |
680 |
$4K |
| 12011 |
|
36 |
28 |
$4K |
| 87529 |
|
1,402 |
756 |
$4K |
| 83880 |
|
1,608 |
1,238 |
$4K |
| 93975 |
|
27 |
26 |
$4K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
26 |
23 |
$4K |
| 80324 |
|
143 |
142 |
$4K |
| 73110 |
|
542 |
468 |
$4K |
| 74018 |
|
186 |
166 |
$3K |
| 82575 |
|
336 |
298 |
$3K |
| 83605 |
|
3,008 |
2,281 |
$3K |
| 87634 |
|
1,291 |
1,117 |
$3K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
340 |
307 |
$3K |
| 73080 |
|
263 |
229 |
$3K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
887 |
790 |
$3K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,288 |
2,049 |
$2K |
| 84702 |
|
918 |
756 |
$2K |
| 43249 |
|
12 |
12 |
$2K |
| 73560 |
|
242 |
203 |
$2K |
| 83690 |
|
8,284 |
7,358 |
$2K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
833 |
745 |
$2K |
| 86901 |
|
1,078 |
876 |
$2K |
| 70491 |
|
18 |
18 |
$2K |
| 87522 |
Neg quan hep c or qual rna |
80 |
66 |
$2K |
| 81025 |
|
6,956 |
6,178 |
$2K |
| 75635 |
|
12 |
12 |
$2K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
887 |
790 |
$2K |
| 85651 |
|
977 |
734 |
$2K |
| 85007 |
|
929 |
659 |
$2K |
| 97116 |
|
109 |
71 |
$2K |
| 80361 |
|
143 |
142 |
$2K |
| 84153 |
|
125 |
108 |
$2K |
| 82043 |
|
283 |
262 |
$2K |
| 84156 |
|
366 |
320 |
$2K |
| 77066 |
Tomosynthesis, mammo |
59 |
53 |
$2K |
| 97535 |
Self-care/home management training, each 15 minutes |
78 |
57 |
$2K |
| 93225 |
|
25 |
16 |
$2K |
| 77065 |
Tomosynthesis, mammo |
59 |
46 |
$2K |
| 80348 |
|
143 |
142 |
$2K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
15 |
12 |
$2K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
2,357 |
972 |
$2K |
| 80373 |
|
143 |
142 |
$2K |
| 72141 |
|
13 |
12 |
$2K |
| 80354 |
|
143 |
142 |
$2K |
| 80346 |
|
143 |
142 |
$2K |
| 70486 |
|
81 |
69 |
$2K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
2,933 |
2,253 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,089 |
1,765 |
$2K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
73 |
60 |
$2K |
| 80372 |
|
143 |
142 |
$2K |
| 80353 |
|
143 |
142 |
$2K |
| 81003 |
|
2,652 |
2,284 |
$2K |
| 80365 |
|
143 |
142 |
$1K |
| 80359 |
|
143 |
142 |
$1K |
| 80358 |
|
143 |
142 |
$1K |
| 71101 |
|
169 |
154 |
$1K |
| 87070 |
|
2,452 |
2,068 |
$1K |
| 85378 |
|
2,026 |
1,721 |
$1K |
| 01999 |
|
535 |
465 |
$1K |
| 87077 |
|
2,063 |
1,607 |
$1K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
76 |
63 |
$1K |
| 84703 |
|
2,973 |
2,724 |
$1K |
| 76536 |
|
12 |
12 |
$1K |
| 87186 |
|
1,741 |
1,402 |
$869.91 |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
20 |
12 |
$866.09 |
| 29125 |
|
397 |
352 |
$816.08 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
2,095 |
1,680 |
$785.55 |
| 87210 |
|
477 |
431 |
$706.96 |
| 87205 |
|
1,869 |
1,494 |
$704.42 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
2,397 |
1,375 |
$672.22 |
| J2704 |
Injection, propofol, 10 mg |
2,222 |
1,919 |
$654.09 |
| 82550 |
|
452 |
346 |
$621.21 |
| 85730 |
|
911 |
743 |
$607.16 |
| 72128 |
|
14 |
12 |
$591.19 |
| 93226 |
|
18 |
13 |
$588.72 |
| 80074 |
|
54 |
41 |
$578.84 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
4,206 |
3,360 |
$564.90 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
7,190 |
5,522 |
$541.90 |
| 73590 |
|
123 |
110 |
$533.02 |
| 84145 |
|
920 |
744 |
$514.82 |
| 86780 |
|
52 |
42 |
$485.97 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,701 |
2,838 |
$467.48 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,606 |
1,153 |
$453.27 |
| 82140 |
|
162 |
123 |
$452.31 |
| 92610 |
|
13 |
13 |
$440.34 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,746 |
1,302 |
$409.55 |
| 87040 |
|
1,328 |
592 |
$399.63 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
13,598 |
7,765 |
$398.88 |
| 70498 |
|
43 |
40 |
$393.84 |
| 85014 |
|
40 |
40 |
$392.76 |
| 88304 |
|
221 |
149 |
$378.92 |
| G0008 |
Administration of influenza virus vaccine |
36 |
27 |
$362.15 |
| 01400 |
|
83 |
67 |
$361.08 |
| 97598 |
|
30 |
12 |
$356.85 |
| 73140 |
|
34 |
29 |
$344.13 |
| 86706 |
|
31 |
26 |
$323.39 |
| J1644 |
Injection, heparin sodium, per 1000 units |
1,073 |
513 |
$270.47 |
| 86334 |
|
56 |
39 |
$265.97 |
| 88342 |
|
987 |
846 |
$262.87 |
| 84132 |
|
497 |
394 |
$258.04 |
| 73090 |
|
67 |
51 |
$254.39 |
| 82248 |
|
83 |
64 |
$251.18 |
| 82950 |
|
28 |
28 |
$244.99 |
| 83970 |
|
12 |
12 |
$207.20 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
964 |
434 |
$200.71 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
440 |
324 |
$199.79 |
| 85018 |
|
40 |
40 |
$196.72 |
| 72170 |
|
146 |
122 |
$194.47 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
440 |
418 |
$169.56 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
628 |
371 |
$160.39 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
1,353 |
628 |
$156.28 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
1,160 |
877 |
$150.75 |
| 86592 |
|
14 |
12 |
$147.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,055 |
676 |
$143.49 |
| 94760 |
|
1,204 |
805 |
$140.58 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
315 |
207 |
$133.64 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
141 |
116 |
$131.48 |
| 86141 |
|
78 |
69 |
$126.13 |
| 84550 |
|
85 |
75 |
$125.36 |
| 82378 |
|
264 |
172 |
$109.08 |
| 83615 |
|
77 |
68 |
$92.47 |
| 84165 |
|
58 |
43 |
$88.65 |
| 82570 |
|
15 |
15 |
$81.68 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,512 |
1,900 |
$80.82 |
| 87486 |
|
26 |
23 |
$74.00 |
| J2060 |
Injection, lorazepam, 2 mg |
893 |
673 |
$72.88 |
| 82010 |
|
158 |
133 |
$68.78 |
| 87176 |
|
89 |
83 |
$56.96 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
115 |
89 |
$46.66 |
| J0689 |
Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg |
494 |
399 |
$46.23 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
202 |
177 |
$45.35 |
| J1940 |
Injection, furosemide, up to 20 mg |
198 |
131 |
$39.46 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
566 |
458 |
$37.65 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
27 |
24 |
$37.00 |
| 87581 |
|
26 |
23 |
$37.00 |
| J3480 |
Injection, potassium chloride, per 2 meq |
231 |
132 |
$29.36 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
77 |
63 |
$29.23 |
| J3360 |
Injection, diazepam, up to 5 mg |
157 |
59 |
$26.96 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
789 |
636 |
$25.85 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
231 |
149 |
$24.39 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
562 |
452 |
$23.15 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
39 |
25 |
$18.28 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
135 |
113 |
$12.86 |
| J7999 |
Compounded drug, not otherwise classified |
28 |
26 |
$11.60 |
| J2800 |
Injection, methocarbamol, up to 10 ml |
13 |
13 |
$8.59 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
147 |
94 |
$8.57 |
| J1630 |
Injection, haloperidol, up to 5 mg |
67 |
38 |
$8.34 |
| J1790 |
Injection, droperidol, up to 5 mg |
79 |
66 |
$4.50 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
60 |
43 |
$3.86 |
| J7510 |
Prednisolone oral, per 5 mg |
12 |
12 |
$2.46 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
184 |
144 |
$2.05 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
472 |
396 |
$0.29 |
| Q0177 |
Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
31 |
28 |
$0.15 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
270 |
228 |
$0.00 |
| 00731 |
|
287 |
254 |
$0.00 |
| 00811 |
|
98 |
96 |
$0.00 |
| 00840 |
|
16 |
13 |
$0.00 |
| C1776 |
Joint device (implantable) |
79 |
68 |
$0.00 |
| J1953 |
Injection, levetiracetam, 10 mg |
14 |
13 |
$0.00 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
17 |
13 |
$0.00 |
| 36592 |
|
17 |
12 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
42 |
30 |
$0.00 |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
14 |
13 |
$0.00 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
315 |
281 |
$0.00 |
| 88311 |
|
77 |
63 |
$0.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
199 |
140 |
$0.00 |
| 94761 |
|
216 |
140 |
$0.00 |
| J2785 |
Injection, regadenoson, 0.1 mg |
77 |
68 |
$0.00 |
| 00813 |
|
128 |
121 |
$0.00 |
| C1769 |
Guide wire |
152 |
123 |
$0.00 |
| C1889 |
Implantable/insertable device, not otherwise classified |
22 |
16 |
$0.00 |
| 00790 |
|
18 |
12 |
$0.00 |
| 74022 |
|
14 |
14 |
$0.00 |